Trade OCSAW stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Oculis Holding AG Warrants (OCSAW) is trading at US$2.51, up 4.38% today as of Oct 9, 16:00 EDT. Over the past 52 weeks, OCSAW has traded between US$2.20 and US$22.64. On Syfe you can trade OCSAW with $0 commission and add it to your watchlist.
| Previous close | US$2.40 |
|---|---|
| 52-week range | US$2.20 – US$22.64 |
| Volume | 500 |
| Exchange | US |
Oculis Holding AG Warrants
Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The firm's pipeline includes multiple product candidates in development such as, OCS-01, a topical retinal candidate for diabetic macular edema, OCS-02, a topical biologic candidate for dry eye disease, and OCS-05, a disease modifying candidate for acute optic neuritis and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The company was founded in 2016 and is headquartered in Zug, Switzerland.
Year: 2023
Oculis Holding AG Warrants (OCSAW) stock is trading at US$2.51, +4.38% from the previous close of US$2.40.
The 52-week high for Oculis Holding AG Warrants (OCSAW) stock is US$22.64.
The 52-week low for Oculis Holding AG Warrants (OCSAW) stock is US$2.20.
Oculis Holding AG Warrants (OCSAW) does not currently pay a dividend.
Stay on top of OCSAW
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
